M 19
LIVE
Serial Number
79317958
Owner
Guangzhou HMC Biotechnology Co.,Ltd.Attorney
xionghui murongFiling Date
May 31, 2021
M 19 Trademark
Serial Number: 79317958 • Registration: 6874584
M 19 is a trademark filed by
Guangzhou HMC Biotechnology Co.,Ltd.
on May 31, 2021. The trademark is classified under Class 3 (Cosmetics & Cleaning).
The application is currently registered and active.
Trademark Classes
Owner Contact Info
Legal Representation
Correspondence Address
XIONGHUI MURONG
12900 Oxon Road
Herndon
VA 20171
UNITED STATES
Trademark Details
Filing Date
May 31, 2021
Registration Date
October 18, 2022
Published for Opposition
August 2, 2022
Filing History
FINAL DECISION TRANSACTION PROCESSED BY IB
Feb 27, 2023 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Feb 3, 2023 FICS
FINAL DISPOSITION PROCESSED
Feb 3, 2023 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jan 18, 2023 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Oct 18, 2022 NRCC
REGISTERED-PRINCIPAL REGISTER
Oct 18, 2022 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 2, 2022 NPUB
PUBLISHED FOR OPPOSITION
Aug 2, 2022 PUBO
NOTIFICATION PROCESSED BY IB
Aug 1, 2022 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jul 13, 2022 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jul 13, 2022 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 13, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 27, 2022 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 17, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 17, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 17, 2022 TROA
REFUSAL PROCESSED BY IB
Apr 11, 2022 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 24, 2022 RFCS
REFUSAL PROCESSED BY MPU
Mar 24, 2022 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Feb 23, 2022 RFCR
NON-FINAL ACTION WRITTEN
Feb 22, 2022 CNRT
ASSIGNED TO EXAMINER
Feb 14, 2022 DOCK
APPLICATION FILING RECEIPT MAILED
Aug 21, 2021 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 17, 2021 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Aug 12, 2021 REPR
